An experimental vaccine has proved effective in a nationwide US study at combatting the incidence and severity of shingles in older adults, according to the findings of a new study. The experimental vaccine was found to reduce the incidence of shingles by just over 50 percent during tests, according to the study which will appear in the June 2 issue of The New England Journal of Medicine."These striking results indicate for the first time that we can use a vaccine to prevent shingles,” said Stephen Straus, an infectious diseases specialist at the National Institute of Allergy and Infectious Diseases, in a statement.
